Congenital short bowel syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2301OMIM:300048Q43.8
Who is this for?
Show terms as
1Active trials19Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital short bowel syndrome (CSBS), also known as congenital short gut syndrome or congenital short small bowel, is an extremely rare condition present at birth in which the small intestine is significantly shorter than normal. In healthy full-term newborns, the small intestine typically measures approximately 200–300 cm, but in CSBS the intestinal length may be dramatically reduced, sometimes to less than one-third of normal. This shortened bowel results in a markedly reduced absorptive surface area, leading to intestinal failure and severe malabsorption of nutrients, fluids, and electrolytes. The condition primarily affects the gastrointestinal system and can be associated with intestinal malrotation. Affected neonates typically present shortly after birth with chronic diarrhea, vomiting, failure to thrive, dehydration, and progressive malnutrition. The exact cause of CSBS is not fully understood, though it is believed to result from a defect in intestinal development during fetal life. Some cases have been linked to mutations in the CLMP gene (encoding CXADR-like membrane protein), which plays a role in intestinal elongation and morphogenesis during embryonic development. Both autosomal recessive and sporadic forms have been described. CSBS must be distinguished from acquired short bowel syndrome, which results from surgical resection of the intestine due to conditions such as necrotizing enterocolitis or volvulus. Management of congenital short bowel syndrome centers on providing adequate nutrition to support growth and development. Most affected infants require long-term total parenteral nutrition (TPN) to bypass the inadequate intestinal absorption. Enteral feeding is gradually introduced as tolerated to promote intestinal adaptation, a process by which the remaining bowel may increase its absorptive capacity over time. Complications of prolonged TPN, including liver disease (intestinal failure-associated liver disease), catheter-related infections, and metabolic disturbances, represent significant challenges. In severe cases where intestinal adaptation is insufficient and TPN-related complications become life-threatening, small bowel transplantation may be considered. Multidisciplinary care involving pediatric gastroenterologists, surgeons, dietitians, and specialized nutrition teams is essential for optimizing outcomes.

Clinical phenotype terms— hover any for plain English:

Intestinal hypoplasiaHP:0005245Displacement of the urethral meatusHP:0100627
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

4 events
Sep 2025A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

Eclipse Regenesis, Inc. — NA

TrialRECRUITING
Jun 2025Safety and Efficacy of Endoscopic Full Thickness Biopsy in Patients With Chronic Intestinal Pseudo-obstruction

International University of Health and Welfare — NA

TrialNOT YET RECRUITING
Jan 2025Effect of Preoperative Intrathecal Dexamethasone Versus Dexmedetomidine on Paralytic Ileus After Major Abdominal Surgery

Assiut University — PHASE4

TrialNOT YET RECRUITING
Jan 2025Predicting NOM Failure in Bowel Obstruction

Centre Hospitalier Universitaire de Nice

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Congenital short bowel syndrome.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
N/A
Actively Recruiting
· Sites: Palo Alto, California; San Francisco, California +4 more · Age: 065 yrs

Specialists

19 foundView all specialists →
XM
Xiaoying Li, MD
Specialist
PI on 1 active trial
LM
Laurent Michaud, MD
Specialist
PI on 2 active trials
MM
Mark Weems, MD
ADA, OK
Specialist
PI on 2 active trials
AM
Alexandra Carey, MD
Specialist
PI on 1 active trial1 Congenital short bowel syndrome publication
CM
Christopher Duggan, MD, MPH
BOSTON, MA
Specialist
PI on 1 active trial
HM
Hans Gerdes, M.D.
NEW YORK, NY
Specialist
PI on 1 active trial
KM
Kittipat Charoenkwan, MD
Specialist
PI on 2 active trials
BM
Brian C. Weiner, MD
COLUMBIA, SC
Specialist
PI on 1 active trial
RT
Rut Anne Thomassen
Specialist
PI on 1 active trial
AP
Anne Charlotte Brun, MD PhD
Specialist
PI on 1 active trial
MS
Muzaffer Sancı
Specialist
PI on 1 active trial
DM
DARLINTON-PETER CHIBUZOR C UGOJI, MBBS
Specialist
PI on 1 active trial
VP
Vin Tangpricha, M.D. Ph.D.
ATLANTA, GA
Specialist
PI on 2 active trials
SP
Stefan Holland-Cunz, Prof
Specialist
PI on 1 active trial
DS
David Sigalet
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital short bowel syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital short bowel syndromeForum →

No community posts yet. Be the first to share your experience with Congenital short bowel syndrome.

Start the conversation →

Latest news about Congenital short bowel syndrome

Disease timeline:

New recruiting trial: A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

A new clinical trial is recruiting patients for Congenital short bowel syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital short bowel syndrome

What is Congenital short bowel syndrome?

Congenital short bowel syndrome (CSBS), also known as congenital short gut syndrome or congenital short small bowel, is an extremely rare condition present at birth in which the small intestine is significantly shorter than normal. In healthy full-term newborns, the small intestine typically measures approximately 200–300 cm, but in CSBS the intestinal length may be dramatically reduced, sometimes to less than one-third of normal. This shortened bowel results in a markedly reduced absorptive surface area, leading to intestinal failure and severe malabsorption of nutrients, fluids, and electrol

At what age does Congenital short bowel syndrome typically begin?

Typical onset of Congenital short bowel syndrome is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Congenital short bowel syndrome?

Yes — 1 recruiting clinical trial is currently listed for Congenital short bowel syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Congenital short bowel syndrome?

19 specialists and care centers treating Congenital short bowel syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.